Aidian's Head of New Technologies & IPR, Mirko Brummer, attended the 5th Munich Point-of-Care Testing Symposium (POCT) September 27–29, 2022...
The influenza season is starting soon in Europe, whereas in Australia, the season is already finishing. According to the surveillance report...
ELITe BeGenius® is a flexible solution for all laboratories interested in improving daily efficiencies and for labs looking to bring more te...
Aidian Connect mobile application brings your QuikRead go® result available anywhere to support treatment decision QuikRead go Instrument a...
Antimicrobial resistance (AMR) is a major global health threat that has already reached alarming levels. Aidian takes part in supporting ant...
Aidian is pleased to announce that Matthias Borst and Dr. Michael Hausmann have been appointed to the company’s board of directors. Both hav...
A new poster about QuikRead go® HbA1c is out now! A new poster about QuikRead go® HbA1c is out now! A study conducted in the Netherlands sh...
Antimicrobial resistance (AMR) is an emerging health threat, but the COVID-19 pandemic set back many actions already combating AMR. Before C...